Mr. Robert B. Ford is a Chairman & Chief Executive Officer at Cardiovascular Systems, Inc., a Chairman, President & Chief Executive Officer at Abbott Laboratories and a Chairman & Chief Executive Officer at Abbott GmbH (Germany). He is on the Board of Directors at California Biomedical Innovation Alliance. Mr. Ford was previously employed as a Senior Vice President by Abbott Diabetes Care, Inc. and a Manager-Diagnostics Business Unit by Abbott Laboratórios do Brasil Ltda. He received his undergraduate degree from Boston College and an MBA from Haas School of Business.
Sally E. Blount
Sally E. Blount is President & Chief Executive Officer at Catholic Charities of the Archdiocese of Chicago since 2020. Serving as Independent Director at Abbott Laboratories since 2011. Director at The Joyce Foundation since 2017. Professor at Northwestern University since 2010. Professor at Kellogg School of Management since 2018. Former Independent Director at Ulta Beauty, Inc. from 2017 to 2022. Former Director at The Economic Club of Chicago from 2017 to 2023. Former Vice Dean & Professor at The Leonard N Stern School of Business from 2004 to 2010. Former Director-Finance & Planning at Eva Maddox Associates. Former Director at The Economic Club of Chicago (Illinois). Completed undergraduate education at Princeton University.
Nancy McKinstry
Ms. Nancy McKinstry is an Independent Director at Accenture Plc, a Lead Independent Director at Abbott Laboratories, a Chairman & Chief Executive Officer at Wolters Kluwer Software und Service GmbH, a Member at European Round Table of Industrialists and a Member-Overseers Board at Columbia Business School. She is on the Board of Directors at Accenture Plc, Russell Reynolds Associates, Inc., Abbott Laboratories, Mondelez International, Inc. and TiasNimbas Business School BV. Ms. McKinstry was previously employed as an Independent Non-Executive Director by Sanoma Oyj, a Chairman by Insurance Corporation of British Columbia, an Independent Director by MortgageIT Holdings, Inc., an Independent Director by Telefon AB LM Ericsson, a Chairman-Executive Board & Chief Executive Officer by Wolters Kluwer NV, a Chief Executive Officer by SCP Communications, Inc., a President & Chief Executive Officer by CCH Legal Information Services, Inc., a Chairman by Wolters Kluwer Tax & Accounting Nederland BV, a Principal by Booz Allen & Hamilton, Inc., a Principal by CCH, Inc., a Chief Executive Officer by Strategy&, a Member by The University Club of New York, a Chief Executive Officer by Wolters Kluwer Health, Inc., and a Chief Executive Officer by Wolters Kluwer North America, Inc. She also served on the board at Ericsson, Inc., Adven Oy, HSBC Bank Canada and The American Chamber of Commerce in the Netherlands. She received her undergraduate degree from the University of Rhode Island and an MBA from The Trustees of Columbia University in The City of New York.
Daniel J. Starks
Daniel J. Starks is an Independent Director at Abbott Laboratories since 2017. Formerly, Mr. Starks was President & Chief Executive Officer at Daig Corp. Mr. Starks was Chairman, President & Chief Executive Officer at Advanced Neuromodulation Systems, Inc. from 2004 to 2016. Mr. Starks was President & Chief Executive Officer at Cardiac Rhythm Management from 1997 to 2001. Mr. Starks was Executive Chairman at St. Jude Medical LLC from 2016 to 2017. Mr. Starks was Chairman at Epicor Medical, Inc. Mr. Starks was Director at Urologix, Inc. from 2002 to 2009.
John G. Stratton
John G. Stratton is currently an Independent Director at Abbott Laboratories since 2017, an Independent Director at General Dynamics Corp. since 2020, a Director at root9B LLC since 2020, and a Director at SubCom LLC. Formerly, Mr. Stratton was Executive Chairman at Frontier Communications Parent, Inc. from 2021 to 2026, Director at CTIA-The Wireless Association from 2015 to 2018, Director at Verizon Connect, Inc., President-Operations & Executive Vice President at Verizon Communications, Inc. from 2015 to 2017, Chief Operating Officer & Executive Vice President at Verizon Wireless, Inc. from 2010 to 2012, President at NYNEX Long Distance Co. from 2012 to 2014, and President-Philadelphia Region at Bell Atlantic Mobile.
Robert B. Ford
Mr. Robert B. Ford is a Chairman & Chief Executive Officer at Cardiovascular Systems, Inc., a Chairman, President & Chief Executive Officer at Abbott Laboratories and a Chairman & Chief Executive Officer at Abbott GmbH (Germany). He is on the Board of Directors at California Biomedical Innovation Alliance. Mr. Ford was previously employed as a Senior Vice President by Abbott Diabetes Care, Inc. and a Manager-Diagnostics Business Unit by Abbott Laboratórios do Brasil Ltda. He received his undergraduate degree from Boston College and an MBA from Haas School of Business.
Michelle A. Kumbier
Ms. Michelle A. Kumbier is an Independent Director at Ryerson Holding Corp., a Senior VP, President-Turf & Consumer Products at Briggs & Stratton LLC, an Independent Director at Teledyne Technologies, Inc. and an Independent Director at Abbott Laboratories. She is on the Board of Directors at Ryerson Holding Corp., Teledyne Technologies, Inc. and Abbott Laboratories. Ms. Kumbier was previously employed as an Independent Director by Tenneco, Inc., a Chief Operating Officer & Senior Vice President by Harley-Davidson Motor Co., Inc., and a Chief Operating Officer & Senior Vice President by Harley-Davidson, Inc. She received her undergraduate degree from Lakeland College and an MBA from the University of Wisconsin Oshkosh.
Darren W. McDew
Mr. Darren W. McDew is an Independent Director at GE Aerospace, an Independent Director at Parsons Corp. and an Independent Director at Abbott Laboratories. He is on the Board of Directors at GE Aerospace, Parsons Corp., Abbott Laboratories, United Services Automobile Association, North America, Inc. and Boys & Girls Clubs of America. Mr. McDew was previously employed as a Manager by United States Department of Defense. He also served on the board at Rolls-Royce North America, Inc. He received his undergraduate degree from Virginia Military Institute and a graduate degree from Embry-Riddle Aeronautical University.
Michael F. Roman
Mr. Michael F. Roman is an Independent Director at Waystar Holding Corp. and an Independent Director at Abbott Laboratories. He is on the Board of Directors at Waystar Holding Corp., Abbott Laboratories and University of Minnesota Foundation. Mr. Roman was previously employed as an Executive Chairman by 3M Co., a President & Managing Director by 3M Korea Co., Ltd., and a Treasurer by Minnesota Medical Foundation. He received his undergraduate degree from the University of Minnesota and a graduate degree from the University of Southern California.
Paola Gonzalez
Paola Gonzalez currently works at Abbott Laboratories, as Independent Director from 2021 and The Clorox Co., as Vice President-Global FP&A from 2023.
Claire L. Babineaux-Fontenot
Claire L. Babineaux-Fontenot is the founder of Cbf Consulting Group, L.L.C., founded in 2017. Current jobs include Independent Director at Abbott Laboratories since 2022, Director at New York Life Insurance Co. since 2021, and Treasurer, Director & Executive Vice President at Thurgood Marshall College Fund, Inc. Former jobs include Chief Executive Officer & Director at Feeding America from 2018 to 2026, Director at Walmart Chile SA, Independent Director at Charah Solutions, Inc. from 2018 to 2019, Treasurer, Chief Tax Officer & Executive VP at Walmart, Inc. from 2014 to 2017, and Partner at Adams & Reese LLP from 2001 to 2004. Education includes undergraduate studies at the University of Louisiana at Lafayette, and graduate degrees from SMU Dedman School of Law and Southern University Law Center.
Michael G. O'Grady
Mr. Michael G. O'Grady is an Independent Director at Abbott Laboratories, a Chairman, President & Chief Executive Officer at Northern Trust Corp. and a Chairman & Chief Executive Officer at Northern Trust of California, NA. He is on the Board of Directors at Abbott Laboratories, Northwestern Medical Group, The Economic Club of Chicago, The Northern Trust Co., World Business Chicago and Catholic Extension Board of Governors. Mr. O'Grady was previously employed as a Managing Director-Investment Banking Group by Merrill Lynch, Pierce, Fenner & Smith, Inc. and a Chairman by The Museum of Contemporary Art (Illinois). He received his undergraduate degree from the University of Notre Dame and an MBA from Harvard Business School.
Nita Ahuja
Nita Ahuja began a role as Independent Director at Abbott Laboratories in 2025 and continues in this position.
Kevin T. Conroy
Kevin T. Conroy is Chief Executive Officer at Genomic Health, Inc. since 2019. He is Independent Director at Align Technology, Inc. since 2023. He serves as President & Director at Paradigm Diagnostics, Inc. He is Director at Wisconsin Technology Council, Greater Madison Chamber of Commerce, and Overture Center Foundation. He is Treasurer & Director at American Clinical Laboratory Association starting 2025. He is Director at LetsGetChecked, Inc. starting 2024 and at Abbott Laboratories starting 2026. Formerly, Mr. Conroy was President & Chief Executive Officer at Third Wave Technologies, Inc. from 2005 to 2008. He was Chairman, President & Chief Executive Officer at EXACT Sciences Corp. from 2014 to 2026. He was Chairman at United Way of Dane County, Inc. He was Director at Bioforward, Inc. He was Independent Director at Epizyme, Inc. from 2017 to 2022, at Adaptive Biotechnologies Corp. from 2019 to 2023, at CM Life Sciences II, Inc. in 2021, at ARYA Sciences Acquisition Corp. from 2018 to 2020, and at SomaLogic, Inc. He was Director at Overture Center For The Arts. He was Partner at McDermott Will & Emery LLP and at Pattishall, McAuliffe, Newbury, Hilliard & Geraldson LLP. He was Counsel-Intellectual Property at GE Healthcare Ltd. (United Kingdom) from 2002 to 2004. Education includes undergraduate studies at Michigan State University and graduate studies at The University of Michigan Law School.
提供，免责声明：天汇财经、Factset及其他信息供应商努力确保所提供信息的准确性和可靠性，但对于其正确性或可靠性则不予担保，且对于因不正确或疏漏所造成的任何损失或损坏概不负责(无论是有关民事过失、合同或其他方面)。